Actavis returns for ATP World Tour Finals

Dublin-based pharmaceuticals company Actavis has signed a two-year extension to its partnership with the Association of Tennis Professionals for its ATP World Tour Finals event.

Actavis first teamed with the ATP Tour’s season-ending showpiece in 2013 and it will now benefit from a court side presence at the tournament through 2015.

London’s O2 Arena will continue its hosting of the competition which pits the top eight men’s tennis players in the world against one another.

Actavis’ senior vice-president of its international pharma division, Lars Ramneborn, said: “Our 2013 partnership was a great success. The ATP World Tour Finals enjoyed a record global television audience and we are convinced that the tennis season finale, with its impressive roster of stars, provides an excellent platform for presenting our brand identity to viewers around the world and the spectators at the tournament.”